Day One Biopharmaceuticals

South San Francisco, United States

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

Jul 2024

Post-IPO Equity

Biopharma Biotechnology Health Care Pharmaceutical

Top Investors

Franklin TempletonRA Capital ManagementWellington ManagementCanaan PartnersJanus Henderson Investors

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Day One Biopharmaceuticals

Who are Day One Biopharmaceuticals's investors?

Day One Biopharmaceuticals's investors include Franklin Templeton, RA Capital Management, Wellington Management, Canaan Partners, Janus Henderson Investors.

Where is Day One Biopharmaceuticals headquartered?

Day One Biopharmaceuticals is headquartered in South San Francisco, United States.

What does Day One Biopharmaceuticals do?

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

What stage is Day One Biopharmaceuticals at?

Day One Biopharmaceuticals is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 30, 2024.

MLA

"Day One Biopharmaceuticals — Funding & Investors." VCBacked, July 30, 2024, https://www.vcbacked.co/company/day-one-biopharmaceuticals. Accessed July 1, 2026.

APA

VCBacked. (2024). Day One Biopharmaceuticals — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/day-one-biopharmaceuticals

Wikipedia (cite web)

{{cite web |title=Day One Biopharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/day-one-biopharmaceuticals |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 30, 2024.